In Vivo

Rebuilding Big Pharma's business model

The blockbuster business model that underpinned Big Pharma's success is now irreparably broken. The industry needs a new approach.

By James Gilbert, Preston Henske and Ashish Singh


The blockbuster business model that underpinned Big Pharma's success is now irreparably broken. The industry needs a new approach. Download the Full Report (pdf)

Speak to our experts in Please select an industry from the dropdown list

We help global leaders with their organization's most critical issues and opportunities. Together, we create enduring change and results

Your work email address Please enter a valid email address